£118.95

Humana Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Price data last checked 84 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 7 days • 7 data points (No recent data available)

Historical
Generating forecast...
£118.95 £118.76 £118.80 £118.84 £118.89 £118.93 £118.97 25 January 2026 26 January 2026 28 January 2026 29 January 2026 31 January 2026

Price Distribution

Price distribution over 7 days • 1 price levels

Days at Price
7 days 0 2 4 5 7 £119 Days at Price

Price Analysis

Most common price: £119 (7 days, 100.0%)

Price range: £119 - £119

Price levels: 1 different prices over 7 days

Description

Product Description This book reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. It also introduces several current approaches developed by established investigators that are aimed at overcoming resistance. This is the first volume to compile studies on tumor cell sensitization. It will prove useful for students, scientists, clinicians and pharmaceutical companies. Review From the reviews: “This book introduces emerging strategies, potential signaling pathways and biomolecules as key targets to sensitize resistant cancers. … detailed information and data can be obtained from the references listed at the end of each chapter. This book helps chemists to enrich their biological insight, and biologists to acquire new chemical strategies in reversing cancer resistance. … the book is also recommended to students in these fields. For scientists in industry and academia, and clinicians, this book provides an overview of current approaches … .” (Yoshihiko Kotake, ChemMedChem, Vol. 4, 2009) From the Back Cover Cancer chemotherapy can be traced back to the 1940’s and since then the world has witnessed the discovery and the important application of several new drugs. The successes of combination chemotherapy suggested that all cancers can be treated provided that the correct combination of drugs at the correct doses and correct intervals are established. However, with time, tumor cells develop mechanisms of resistance to apoptosis and no longer respond to the majority of cytotoxic therapies. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy, edited by Benjamin Bonavida, reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. Such sensitizing agents target gene products that regulate resistance and therefore identify novel targets for drug development. This book also introduces several of the current approaches that have been developed by established investigators in the field that are aimed at overcoming resistance. This book is the first that compiles studies on tumor cell sensitization and is useful for students, scientists, clinicians and pharmaceutical companies.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
19 November 2010
Listed Since
01 October 2010

Barcode

No barcode data available

Similar Products You Might Like

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)
99% match

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Humana

£38.00 25 Jan 2026
Cancer Cell Chemoresistance And Chemosensitization
95% match

Cancer Cell Chemoresistance And Chemosensitization

Scientific Publishing

£148.00 11 Mar 2026
Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
95% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Academic Press

£111.19 10 Mar 2026
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
94% match

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Humana

£149.75 13 Jan 2026
Springer - Resistance to Immunotherapeutic Antibodies in Cancer
94% match

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Springer

£107.61 17 Apr 2026
Humana - Increasing the Therapeutic Ratio of Radiotherapy
94% match

Humana - Increasing the Therapeutic Ratio of Radiotherapy

Humana

£107.85 20 Apr 2026
Cancer Drug Resistance (Cancer Drug Discovery and Development)
94% match

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Humana

£154.49 13 Jan 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
94% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.09 28 Feb 2026
Humana Combination Cancer Therapy: Modulators and Potentiators
94% match

Humana Combination Cancer Therapy: Modulators and Potentiators

Humana

£34.76 18 Apr 2026
Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)
94% match

Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)

Humana

£84.34 23 Feb 2026
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
94% match

Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance

Academic Press

£98.89 09 Mar 2026
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
94% match

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Humana

£104.04 19 Apr 2026
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy (Volume 18) (Cancer Sensitizing Agents for Chemotherapy, Volume 18)
94% match

Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy (Volume 18) (Cancer Sensitizing Agents for Chemotherapy, Volume 18)

Academic Press

£115.58 10 Mar 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
94% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£147.91 10 Mar 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
94% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£117.40 15 Jan 2026
Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)
94% match

Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)

Humana

£84.08 18 Feb 2026
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
94% match

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Humana

£72.83 08 Mar 2026
CRC Press Radiosensitizers and Radiochemotherapy in Cancer
94% match

CRC Press Radiosensitizers and Radiochemotherapy in Cancer

CRC Press

£91.61 15 Apr 2026
Nitric Oxide (Donor/Induced) in Chemosensitization (Volume 1) (Cancer Sensitizing Agents for Chemotherapy, Volume 1)
94% match

Nitric Oxide (Donor/Induced) in Chemosensitization (Volume 1) (Cancer Sensitizing Agents for Chemotherapy, Volume 1)

Academic Press

£110.25 10 Mar 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
94% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
94% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Stem Cells and Cancer (Cancer Drug Discovery and Development)
94% match

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Humana

£149.20 27 Jan 2026
Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)
94% match

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Humana

£102.99 04 Apr 2026
Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)
94% match

Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£144.18 08 Mar 2026